StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Oculis Holding AG
NasdaqGM:OCS
Sector
Location
Market Cap
USD 969.64 M
Share Price
USD 19.00
Avg Daily Volume
36,771
Change (1 day)
-0.83%
Change (1 year)
61.98%
Change (YTD)
11.77%
Oculis Holding AG Market Capitalization on July 03, 2025: USD 969.64 M
Oculis Holding AG Market Capitalization is USD 969.64 M on July 03, 2025, a 97.08% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
-
Oculis Holding AG 52-week low Market Capitalization is USD 1.10 B on July 03, 2025, which is 13.68% above the current Market Capitalization.
-
Oculis Holding AG 52-week low Market Capitalization is USD 458.88 M on July 03, 2025, which is -52.68% below the current Market Capitalization.
-
Oculis Holding AG average Market Capitalization for the last 52 weeks is USD 764.50 M.
Competitors
Glaukos Corporation
USD 103.50
GKOS
-0.13
-0.12%
Santen Pharmaceutical Co., Ltd.
USD 11.58
4536.T
+0.16
1.36%
PharmaResearch Co., Ltd.
USD 360.02
214450.KQ
-5.62
-1.54%
Bausch Health Companies Inc.
USD 6.90
BHC.TO
-0.04
-0.62%
Shenyang Xingqi Pharmaceutical Co.,Ltd
USD 7.30
300573.SZ
+0.01
0.17%
Tarsus Pharmaceuticals, Inc.
USD 41.15
TARS
+0.70
1.73%
Ocular Therapeutix, Inc.
USD 9.62
OCUL
+0.16
1.69%
Eli Lilly and Company
USD 780.67
LLY
+1.39
0.18%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Key Data
| Date | Market Capitalization | Share Price | Share Price | Price to Earnings Ratio (P/E) |
|---|
Competitors
Glaukos Corporation
USD 103.50
GKOS
-0.13
-0.12%
Santen Pharmaceutical Co., Ltd.
USD 11.58
4536.T
+0.16
1.36%
PharmaResearch Co., Ltd.
USD 360.02
214450.KQ
-5.62
-1.54%
Bausch Health Companies Inc.
USD 6.90
BHC.TO
-0.04
-0.62%
Shenyang Xingqi Pharmaceutical Co.,Ltd
USD 7.30
300573.SZ
+0.01
0.17%
Tarsus Pharmaceuticals, Inc.
USD 41.15
TARS
+0.70
1.73%
Ocular Therapeutix, Inc.
USD 9.62
OCUL
+0.16
1.69%
Eli Lilly and Company
USD 780.67
LLY
+1.39
0.18%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%